Fate Therapeutics Inc

2
NAS:FATE (USA)  
$ 6.96 +0.08 (+1.16%) 10:08 PM EST
At Loss
P/B:
1.70
Market Cap:
$ 685.78M
Enterprise V:
$ 441.00M
Volume:
1.37M
Avg Vol (2M):
2.96M
Also Trade In:
Volume:
1.37M
At Loss
Avg Vol (2M):
2.96M
Market Cap $ M 685.78
Enterprise Value $ M 441.00
P/E(ttm) --
PE Ratio without NRI --
Forward PE Ratio --
Price/Book 1.70
Price/Sales 6.40
Price/Free Cash Flow --
Price/Owner Earnings --
Payout Ratio % --
Revenue (TTM) $ M 106.00
EPS (TTM) $ -1.77
Beneish M-Score -3.15
10-y EBITDA Growth Rate % -3.10
5-y EBITDA Growth Rate % -25.10
y-y EBITDA Growth Rate % --
EV-to-EBIT -2.13
EV-to-EBITDA -2.34
PEG --
Shares Outstanding M 98.60
Net Margin (%) -163.04
Operating Margin % -194.76
Pre-tax Margin (%) -163.04
Quick Ratio 8.81
Current Ratio 8.81
ROA % (ttm) -26.94
ROE % (ttm) -37.32
ROIC % (ttm) -94.00
Dividend Yield % --
Altman Z-Score -0.23
Piotroski F-Score 4.00
Positive ROA N
Positive CFROA N
Higher ROA y-y Y
Cash flow > Earnings Y
Lower Leverage y-y N
Higher Current Ratio y-y Y
Less Shares Outstanding y-y N
Gross Margin Increase y-y N
Higher Asset Turnover y-y Y

FATE Number of Guru Trades

To

FATE Volume of Guru Trades

To

Gurus Latest Trades with NAS:FATE

No Available Data

NAS:FATE is held by these investors

Guru
Portfolio Date
Current Shares
% of Shares outstanding
% of Total Assets Managed
Comment
Robert Bruce 2023-12-31
143,000
0.15
0.19%
Reduce -28.5%
Total 1

Fate Therapeutics Inc Insider Transactions

No Available Data

News about NAS:FATE

Total 0
  • 1